Vonoprazan in Management of Refractory Gastroesophageal Reflux Disease: An Indian Expert Group Consensus Statements
Journal of The Association of Physicians of India · 2025-02 · 73 (3) · e29-e36
DOI: 10.59556/japi.73.0878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Association of Physicians of India, 2025-02. Verfasst von Philip Abraham und 37 weiteren Autor:innen. Beteiligte Einrichtung: Consultant, Department of Gastroenterology, Hinduja Hospital, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Sulfonamides, Pyrroles, Proton Pump Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Consultant, Department of Gastroenterology, Hinduja Hospital, Mumbai, Maharashtra, India.
- Director and Head, Department of Gastroenterology and Hepatobiliary Sciences, Fortis Memorial Research Institute, Gurugram, Haryana, India.
- Consultant and Director, Dr Deshmukh's Mediliv Hospital, Nashik, Maharashtra, India.
- Head, Department of Gastroenterology, Manipal Hospital, Ghaziabad, Uttar Pradesh, India.
- Senior Consultant, Shilpa Medical Research Centre, Mumbai, Maharashtra, India.
- Director, Department of Gastro Sciences, Paras Health, Panchkula, Haryana, India.
Zitieren
APA
Abraham, P., Choudhuri, G., Deshmukh, S., Kak, M., Tiwaskar, M., Kochhar, R., Sinha, S. K., Panigrahi, S. C., Shandil, R., Khanna, M., Garg, R., Lamba, G. S., Jain, M., Poddar, P., Mishra, A., Shah, A., Kantharia, C., Shah, H., Saha, I., …, & Kumar, V. (2025). Vonoprazan in Management of Refractory Gastroesophageal Reflux Disease: An Indian Expert Group Consensus Statements. Journal of The Association of Physicians of India, 73(3), e29-e36. https://doi.org/10.59556/japi.73.0878
Vancouver
Abraham P, Choudhuri G, Deshmukh S, Kak M, Tiwaskar M, Kochhar R, et al. Vonoprazan in Management of Refractory Gastroesophageal Reflux Disease: An Indian Expert Group Consensus Statements. Journal of The Association of Physicians of India. 2025;73(3):e29-e36. doi:10.59556/japi.73.0878
BibTeX
@article{Abraham2025,
author = {Abraham, Philip and Choudhuri, Gouradas and Deshmukh, Sharad and Kak, Manish and Tiwaskar, Mangesh and Kochhar, Rakesh and Sinha, S K and Panigrahi, S C and Shandil, Rajeev and Khanna, Molina and Garg, Ramesh and Lamba, G S and Jain, Monika and Poddar, Prateik and Mishra, Ajay and Shah, Apurva and Kantharia, Chetan and Shah, Hardik and Saha, Indraneel and Vazifdar, Khurshid and Jain, Lokesh and Borse, Nitin and Garg, Pallavi and Kumar, Manoj and Sahu, Manoj and Nath, Preetam and Singh, Rajdeep and Sahu, Vikram and Bandyopadhyay, Sanjay and Jaiswal, Saurabh and Patil, Dinesh and Bodas, Shripad and Vaghasia, Smit and Khanna, Sudeep and Swami, Onkar C and Chakravarty, Suneel and Murthy, K Vamsi and Kumar, Vinod},
title = {Vonoprazan in Management of Refractory Gastroesophageal Reflux Disease: An Indian Expert Group Consensus Statements},
journal = {Journal of The Association of Physicians of India},
year = {2025},
volume = {73},
number = {3},
pages = {e29--e36},
doi = {10.59556/japi.73.0878}
}
EUVIMED